Myelofibrosis News

This RSS feed URL is deprecated


This RSS feed URL is deprecated, please update. New URLs can be found in the footers at https://news.google.com/news

Emerging Treatments Show Promise in Myelofibrosis - OncLive



OncLive
 
Emerging Treatments Show Promise in Myelofibrosis 
OncLive
The phase III SIMPLIFY-2 trial missed its primary endpoint of superiority with momelotinib in patients with myelofibrosis who had a reduction in spleen volume at 24 weeks for momelotinib versus best alternative therapy at 6.7% versus 5.8%, respectively ...

 


Dr. Mims on the Current Challenges With Myelofibrosis - OncLive



OncLive
 
Dr. Mims on the Current Challenges With Myelofibrosis 
OncLive
Alice S. Mims, MD, assistant professor of medicine, Ohio State University Comprehensive Cancer Center, discusses the current challenges with myelofibrosis. Most patients are not candidates for allogeneic transplants, which is the only myelofibrosis ...

and more » 


Gwar Guitarist Michael Derks Diagnosed With Rare Bone Marrow Cancer - Billboard



Billboard
 
Gwar Guitarist Michael Derks Diagnosed With Rare Bone Marrow Cancer 
Billboard
Michael Derks (stage name BälSäc the Jaws 'o Death) of Gwar is battling myelofibrosis, a rare form of bone marrow cancer. The disease "causes scarring inside of the bones and interferes with the marrow's ability to produce blood cells," he says. Derks ...
GWAR guitarist diagnosed with bone marrow disorder Alternative Press
GWAR's Balsac has cancer; Misfits' Doyle gets eye surgery Brooklyn Vegan (blog)
GWAR guitarist Michael Derks diagnosed with bone marrow cancer NME.com
Richmond magazine (blog)  -mxdwn.com  -Music Feeds  -Virtual Donor Drive - DKMS 
all 10 news articles » 


Dr. Mims Discusses Momelotinib in Myelofibrosis - OncLive



OncLive
 
Dr. Mims Discusses Momelotinib in Myelofibrosis 
OncLive
Alice S. Mims, MD, assistant professor of medicine, The Ohio State University Comprehensive Cancer Center, discusses momelotinib in patients with myelofibrosis. The SIMPLIFY-1 study investigated momelotinib to determine if it was non-inferior to ...

and more » 


Myelofibrosis Treatment Market ? Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2017?2025 - Medgadget (blog)



Myelofibrosis Treatment Market ? Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2017?2025 
Medgadget (blog)
Myelofibrosis is a bone marrow disease that interrupts the blood cells production process in the body. Fibrous or scar tissue gets developed in the bone marrow leading to scarring causing insufficient blood cell production. Myelofibrosis is a rare type ...

 


Myelofibrosis Industry-Epidemiology Dynamics, Segments ,Forecast to 2025 - Medgadget (blog)



Myelofibrosis Industry-Epidemiology Dynamics, Segments ,Forecast to 2025 
Medgadget (blog)
?Myelofibrosis -Epidemiology Forecast, 2025? provides an overview of the epidemiology trends of Myelofibrosis in seven major markets (US, France, Germany, Italy, Spain, UK and Japan). It includes 10 years epidemiology historical and forecasted data of ...

and more » 


Important Research On Chiropractic Care For A Patient With Myelofibrosis Published - Digital Journal



Digital Journal
 
Important Research On Chiropractic Care For A Patient With Myelofibrosis Published 
Digital Journal
Dr Eric Chu, New York Medical Group and Dr Raymond Wong, head of Cancer & Department of Medicine & Therapeutics, CUHK had reported a research case where pain control was satisfactory with chiropractic care in a patient with myelofibrosis. CDAHK ...

 


Terminated Blood Cancer Drug Springs Back to Life at SD Biotech - Xconomy



Xconomy
 
Terminated Blood Cancer Drug Springs Back to Life at SD Biotech 
Xconomy
The study details the results from JAKARTA-2, which evaluated the safety and efficacy of fedratinib in 97 patients with intermediate or high-risk myelofibrosis, a rare bone marrow disorder with a grim prognosis. Hood said fedratinib elicited a stronger ...
Impact Biomedicines Raises $90M In Structured Financing socalTech.com

all 2 news articles » 


Myelofibrosis: Complete Product Development Cycle Analyzed in a ... - Medgadget (blog)



Myelofibrosis: Complete Product Development Cycle Analyzed in a ... 
Medgadget (blog)
Latest 'Myelofibrosis-Pipeline Insights' market research report: Get insight of all the latest development in the industry and affects of current findings.

and more » 


Perry football: Lineman Philip Bentley wants state title for father with cancer - News-Herald.com



News-Herald.com
 
Perry football: Lineman Philip Bentley wants state title for father with cancer 
News-Herald.com
Philip Bentley, starting right guard for the Perry football team, has a tattoo of cross with a cancer ribbon wrapped around it to honor his father Phil, who has put off a search for a bone marrow donor until his son's senior year of football is ...